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Edited by Gianni CesareniAbstract Epithelial–mesenchymal transition (EMT), a process
whereby renal tubular epithelial cells lose phenotype and gain
ﬁbroblast-like characteristics, has been demonstrated to contrib-
ute signiﬁcantly to the development of renal ﬁbrosis. The immu-
nosuppressant cyclosporine A (CsA) has been shown to induce
renal ﬁbrosis, a major complication of CsA therapy. The mech-
anisms that drive CsA-induced ﬁbrosis remain undeﬁned, how-
ever, CsA has been demonstrated to induce EMT in human
renal proximal tubular epithelial cells (RPTEC). E2A transcrip-
tion factors were identiﬁed as being upregulated by CsA treat-
ment. To further examine the role of E2A proteins in EMT,
E12 and E47 were overexpressed, alone and in combination, in
human RPTEC. Both E12 and E47 elicited EMT eﬀects on
tubular epithelial cells with E47 more potent in inducing the
ﬁbroblast-like phenotype. These results indicate the important
role of the E2A gene products in the progression of CsA-induced
EMT and provide novel insights into CsA-induced renal ﬁbrosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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End stage renal disease (ESRD) is one of the most serious
complications associated with hypertension, diabetes and the
use of certain therapeutic drugs. The powerful immunosup-
pressant cyclosporine A (CsA) has revolutionised the ﬁeld of
whole organ transplantation leading to greatly improved sur-
vival and quality of life among graft recipients [1]. However,
a major limiting factor in the use of CsA are toxic eﬀects that
occur in the kidney [2]. Long-term CsA treatment leads to irre-
versible ESRD, characterised by extensive tubulointerstitial
ﬁbrosis (TIF) [3]. TIF is characterised by interstitial thickening
caused by the accumulation of extracellular matrix (ECM)
components [4]. Previously, it was believed that the main
source of the ECM that accumulates during TIF was inﬁltrat-Abbreviations: ESRD, end stage renal disease; TIF, tubulointerstitial
ﬁbrosis; CsA, Cyclosporine A; ECM, extracellular matrix; PTEC(s),
proximal tubular epithelial cell(s); EMT, epithelial–mesenchymal tra-
nsition; a-SMA, alpha-smooth muscle actin; HK-2, human kidney 2;
RPTEC, renal proximal tubular epithelial cells; TGF-b1, transforming
growth factor-beta 1
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doi:10.1016/j.febslet.2006.06.039ing ﬁbroblasts that became active in the interstitium [5]. Accu-
mulated evidence now suggests that a major source of these
active ﬁbroblasts or myoﬁbroblasts is the renal epithelium it-
self through a process termed epithelial–mesenchymal transi-
tion (EMT) [6]. EMT is a process where numerous
phenotypic changes occur leading to the loss of epithelial
markers and function and the acquisition of a ﬁbroblastic phe-
notype, termed a myoﬁbroblast [7]. We have previously re-
ported that human proximal tubular epithelial cells (PTECs)
exposed to CsA over 72 h underwent EMT [8,9]. Transforming
growth factor b1 (TGF-b1) was identiﬁed as being a key medi-
ator of this eﬀect. Since EMT involves a gross change in cell
phenotype, the process likely involves a remarkable alteration
in the complement of genes being expressed. Large scale gene
expression analysis of models of EMT has detected hundreds
of genes with altered expression [10,11]. The main challenge
lies is determining which changes are causative and which
are consequential.
Yang and Liu [7] have proposed that EMT is an orches-
trated stepwise process involving a number of key events that
mark progress from a tubular epithelial cell to a myoﬁbroblast.
These include (i) loss of epithelial cell–cell adhesion and actin
cytoskeletal rearrangement, (ii) de novo synthesis of myoﬁbro-
blast speciﬁc marker proteins (e.g. a-SMA), (iii) disruption of
the tubular basement membrane, and (iv) enhanced cell migra-
tion and invasiveness [7]. However, elucidation of the relation-
ship between these events and the control mechanisms
involved in the EMT process is still ongoing. Regulation of
the morphological and phenotypic changes observed during
EMT occurs, for the most part, at the level of transcription.
Therefore, CsA-induced alterations in the expression of tran-
scriptional regulators were investigated. The E2A gene was
identiﬁed as being upregulated by CsA in this model [8]. The
E2A gene encodes two distinct basic helix-loop-helix (bHLH)
transcription factors, E12 and E47 [12]. The two proteins dis-
play diﬀerences only in their bHLH regions which still main-
tain over 72% amino acid sequence homology [13]. Both
proteins contain a basic region necessary for DNA binding
and a HLH structure that facilitates dimerisation with other
bHLH proteins [12]. E12 and E47 modulate the expression
of their target genes through the formation of homodimers
(E12/E12 and E47/E47), heterodimers with each other (E12/
E47) and heterodimers with other bHLH transcription factors
(E12/MyoD, E47/snail) [14,15]. These bHLH proteins are
thought to play critical roles in the regulation of cell commit-
ment, growth and diﬀerentiation in a range of cell types includ-
ing lymphocytes, muscle cells and neurons [15,16]. Theblished by Elsevier B.V. All rights reserved.
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regulating cell phenotype suggested a role for E2A in this
CsA-induced model of EMT and this was further investigated.2. Materials and methods
2.1. Reagents
CsA was a generous gift from Novartis Pharmaceuticals Ltd. All tis-
sue culture reagents were from Costar. CsA was prepared as a stock
solution (4.2 mmol/L) by dissolving the powder in 100% ethanol. Prim-
ers for RT-PCR were obtained from Sigma Genosys Biotechnologies
(Woodlands, TX). All other reagents were of the highest available pur-
ity from commercial sources. Vectors containing the full-length
cDNAs encompassing the respective coding regions of human E12
and E47 were a generous gift from Dr. Carme Gallego, Departament
de Cie`ncies Me`diques Ba`siques, Universitat de Lleida, 25008 Lleida,
Catalunya, Spain, with the kind permission of Dr. Masataka Nakam-
ura, Tokyo Medical and Dental University, Human Gene Sciences
Center, Tokyo, Japan (previously described [17]) and Dr. Cornelis
Murre, University of California, San Diego (previously described [18]).
2.2. Cell culture and transfection
The human renal proximal tubular cell line, HK-2, was purchased
from American Type Culture Collection (Manassas, VA) and main-
tained in Dulbeccos modiﬁed Eagle’s medium containing 100 U/ml
penicillin, 100 g/ml streptomycin, 5 lg/ml insulin, 10 ng/ml epidermal
growth factor and 2 mM L-glutamine. Primary human renal proximal
tubular epithelial cells (RPTEC) were purchased from Clonetics (Walk-
ersville, MD). Primary tubular epithelial cells were maintained in Renal
Epithelial Cell Growth medium (REGM) supplemented with REGM
SingleQuots and Growth Factors (also Clonetics). Cell culture medium
was changed every 48 h. Cells were maintained in 75 cm2 Costar ﬂasks
at 37 C in a humidiﬁed atmosphere containing 95% air and 5% CO2.
For transfections, HK-2 cells were seeded on 6 well plates at 5 · 103
cells/ml 24 h prior to treatment resulting in approximately 60% conﬂu-
ency at the time of transfection. Cells were transfected with FuGene 6
reagent (Roche), either with 1.75 lg of pcDNA mammalian expression
vector containing a cDNA insert encoding E12 or 1.75 lg pcDNA
mammalian expression vector containing a cDNA insert encoding
E47. Cells were transfected for 24 h at which time further treatments
were performed. The aim of this study was to examine if overexpression
of E2A proteins, alone or in combination, could elicit similar eﬀects to
those observed in response to CsA treatment. Therefore, for the pur-
poses of this study, transient transfectants were created.
2.3. Cell treatment
Cells were treated with a physiologically relevant dose of 4.2 lM
CsA and the eﬀects were examined at 12, 24, 48 and 72 h post-treat-
ment. In all experiments with CsA, control cells were exposed to an
appropriate concentration of ethanol vehicle.
2.4. Immunoﬂuorescent microscopy
Cells were cultured on 8-well chamber slides. After transfection and
treatment, cells were ﬁxed in 3.7% (v/v) formaldehyde/PBS. F-actin
was visualised by direct immunoﬂuoresence using rhodamine phalloi-
din (Molecular Probes) was added as a 1:40 dilution. Cells being
stained for E2A and a-SMA were incubated with a 1:100 dilution of
mouse anti-E2A (Santa Cruz Technology), or mouse anti-a-SMA (Sig-
ma). Subsequently the cells were incubated with secondary antibody
(1:100 rabbit anti-mouse ﬂuorescein isothiocyanate (DAKO)). Cells
were incubated with secondary antibodies in the absence of primary
antibody to demonstrate background staining. Slides were mounted
and viewed using the Zeiss Axioplan 2 imaging ﬂuorescent microscope.2.5. Western blot analysis
Equal total protein amounts of cell lysates or nuclear fractions were
electrophoresed using the procedure of Laemmli [19]. For detection of
E2A proteins and E-cadherin, membranes were probed with antibodies
speciﬁc for E2A proteins (1:500 dilution, Santa Cruz) and E-cadherin
(1:1000 dilution, Transduction Labs) and results shown are representa-
tive of at least three experiments with similar results.2.6. Detection of E2A/E47 DNA-binding activity by electrophoretic
mobility shift assay (EMSA)
Nuclear fractions of adherent cells were obtained using the Proteo-
Extract subcellular proteome extraction kit (Calbiochem), as per man-
ufacturer’s instructions. Detection of E2A/E47 DNA-binding activity
by EMSA was detected using the non-radioactive EMSA kit (Panom-
ics), as per manufacturer’s instructions.2.7. Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated using Trizol reagent (Invitrogen) and quan-
titated by absorbance at 260 nm. RT-PCR primer pairs were designed
using PRIMER 3 software (available at www.genome.wi.mit.edu/cgi-
bin/primer/primer3_www.cgi) and using sequence data available at
the NCBI database. Primers used for ﬁbronectin were: GAPDH –
forward: 5 0ACCACAGTCCATGCCATCAC 3 0, reverse: 5 0 TCCAC-
CACCCTGTTGCTGTA 3 0; a-SMA – forward: 5 0 GCGTGGCT-
ATTCCTTCGTTAC 3 0, reverse: 5 0 CATAGTGGTGCCCCCTGA-
TAG 3 0.
A Gibco-BRL RT kit was used to generate cDNA. 2 ll of the cDNA
was taken from each sample and inserted into 0.5 ml PCR tubes along
with 1 ll of forward primer (100 ng/ll), 1 ll of reverse primer (100 ng/
ll), 2 ll of 10 mM dNTPs, 5 ll of 10· buﬀer, 3 ll of 25 mM MgCl2,
0.25 ll of Taq Polymerase (Promega) and 35.75 ll of sterile distilled
water to bring the volume up to 50 ll. The number of PCR cycles used
were determined to be within the linear range of the reactions. mRNA
levels of the glyceraldehyde phosphate dehydrogenase gene (GAPDH)
were used as a normalisation control.3. Results
3.1. Eﬀect of CsA on HK-2 tubular epithelial cell E2A
expression levels
Exposure of HK-2 tubular epithelial cells to 4.2 lM CsA for
periods up to 72 h resulted in signiﬁcant upregulation of E2A
proteins as demonstrated by Western blot analysis of nuclear
fractions (Fig. 1A). This upregulation was also evident when
E2A proteins were visualised using immunoﬂuorescent micros-
copy demonstrating increased E2A expression at 72 h
(Fig. 1B). Exposure of primary human proximal tubular epi-
thelial cells to 4.2 lM CsA for periods up to 72 h resulted in
signiﬁcant upregulation of E2A proteins similar to that ob-
served in HK-2 cells, as demonstrated by Western blot analysis
of nuclear fractions (Fig. 1C).3.2. Eﬀect of CsA on E2A DNA-binding activity in HK-2
tubular epithelial cells
Transcription factors E12 and E47, encoded in the E2A gene
bind to E-box DNA motifs in the promoters of target genes to
modulate transcription. The eﬀects of CsA on E12/E47 DNA-
binding activity were assessed in HK-2 cells using the EMSA
described in Section 2. Low, basal levels of E12/E47 DNA-
binding activity were detected in control cells at 24, 48 and
72 h (Fig. 2). Markedly higher levels of E12/E47 DNA-binding
activity were detected in cells treated with 4.2 lM CsA at 24,
48 and 72 h.3.3. Overexpression of E2A transcription factors in HK-2
tubular epithelial cells
The overexpression of E12 and E47 in whole cell lysates was
assessed by Western blot analysis (Fig. 3). In mock transfected
HK-2 cells, E12/E47 levels were barely detectable. Treatment
of these cells with 4.2 lM CsA resulted in increased expression
of E12/E47. In transfected cells, overexpression of E12 or E47
Fig. 1. Eﬀect of 4.2 lMCsA on HK-2 tubular epithelial cell E2A expression. HK-2 cells and primary human tubular epithelial cells were grown on 6-
well culture plates or tissue culture slides. Cells were treated with medium containing 4.2 lMCsA for 0, 12, 48 or 72 h. (A) Nuclear fractions obtained
from HK-2 cells were subjected to SDS–PAGE and probed with an antibody directed against E2A. Bands were visualised by ECL. Images shown are
representative of at least three independent experiments. Band intensity was quantiﬁed densitometrically. *(P < 0.05), **(P < 0.01) and ***(P < 0.001)
indicates statistically signiﬁcant diﬀerence compared to control. (B) E2A proteins were visualised using indirect immunoﬂuorescence staining
(magniﬁcation 400·) Images are representative of at least three independent experiments. (C) Nuclear fractions obtained from primary human
tubular epithelial cells were subjected to SDS–PAGE and probed with an antibody directed against E2A. Bands were visualised by ECL. Images
shown are representative of at least three independent experiments. Band intensity was quantiﬁed densitometrically. *(P < 0.05), **(P < 0.01) and
***(P < 0.001) indicates statistically signiﬁcant diﬀerence compared to control.
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protein loading.
3.4. Eﬀects of E12 and E47 overexpression on the morphology of
HK-2 tubular epithelial cells
The eﬀects of E12 and E47 overexpression on HK-2 tubular
epithelial cell morphology were assessed at 48 h by phase-con-
trast microscopy (Fig. 4). Cells were then cultured under the
indicated conditions for a further 48 h. In all cases,mock-transfected HK-2 cells formed a conﬂuent monolayer
exhibiting normal epithelial characteristics. Individual cells
displayed typical epithelial, polygonal shape with a high degree
of attachment to neighboring cells (Fig. 4A). The morphology
of E12-transfected HK-2 cells cultured with control medium
was very similar to that of mock-transfected control cells,
though some cell elongation was evident (Fig. 4C). E12-trans-
fected cells exposed to 4.2 lM CsA exhibited very clear mor-
phological changes similar to, but perhaps more pronounced
Fig. 2. Eﬀect of 4.2 lM CsA on E47/E2A DNA-binding activity in
HK-2 tubular epithelial cells. HK-2 cells grown on 6-well culture plates
were treated with control medium or medium containing 4.2 mM CsA
for 24, 48 or 72 h. Nuclear fractions obtained were analysed for E2A/
E47 DNA-binding activity using the EMSA assay described in Section
2.6. Bands were visualised by ECL. Blot shown is representative of at
least three independent experiments.
4024 C. Slattery et al. / FEBS Letters 580 (2006) 4021–4030than those observed with CsA treatment of mock transfectants
(Fig. 4B and D). E47-transfected cells exhibited striking mor-
phological changes compared to mock transfected control cells
(Fig. 4E). Cells displayed a more elongated shape with a large
degree of cell detachment, similar to those observed previously
in CsA-treated mock transfectants. CsA treatment of cells
overexpressing E47 resulted in almost complete loss of epithe-
lial morphology (Fig. 4F). Cells were notably elongated and
spindle-like with widespread lack of cell–cell attachments, fea-
tures associated with ﬁbroblast-like cells. Overexpression of
E12 and 47 in combination resulted in very signiﬁcant mor-
phological alterations similar to but more pronounced than
those observed in E47-overexpressing cells (Fig. 4G). Treat-
ment of these cells with CsA resulted in almost complete loss
of epithelial morphological characteristics. In fact the mor-
phology of cells overexpressing E12 and E47 was so altered
that the addition of CsA did not signiﬁcantly aﬀect the mor-
phology of these cells (Fig. 4H).Fig. 3. E12/E47 overexpression in HK-2 tubular epithelial cells. HK-2 cells
amounts of a pcDNA3-E12 expression vector, a pcDNA3-E47 expression ve
Whole cell lysates obtained were subjected to SDS–PAGE and probed with
control. Bands were visualised by ECL. Blots shown are representative of a3.5. Eﬀects of E12 and E47 overexpression on F-actin
cytoskeletal arrangement in HK-2 cells
Immunoﬂuorescent microscopy was used to examine the ef-
fects of E12 and E47 on F-actin cytoskeletal arrangement in
human proximal tubular cells (Fig. 5). In all experiments, F-ac-
tin ﬁbres in mock-transfected control cells were densely ar-
ranged just inside the cell periphery, where they associated to
form a circular bundle (Fig. 5A). This organisation is charac-
teristic of cells with apical-basolateral polarity, such as normal
epithelial cells. In cells exposed to 4.2 lM CsA, reorganisation
of the F-actin cytoskeleton was observed (Fig. 5B). The dense
peripheral arrangement of F-actin was redistributed into stress
ﬁbres. In cells overexpressing E12, some alterations in F-actin
cytoskeletal arrangement were observed but principle F-actin
structures were preserved (Fig. 5C). Treatment of these cells
with 4.2 lM CsA resulted in greater F-actin rearrangement
compared to that observed in CsA-treated mock transfectants
(Fig. 5D). Overexpression of E47 resulted in marked reorgani-
sation of the F-actin cytoskeleton (Fig. 5E). Stress ﬁbres were
evident as was the disruption of cell–cell contacts. Treatment
of these cells with CsA resulted in augmentation of these eﬀects
(Fig. 5F). Overexpression of E12 and E47 in combination pro-
duced some of the most striking eﬀects observed (Fig. 5G).
Widespread stress ﬁbre formation and cell detachment was evi-
dent. Exposure of E12/E47 overexpressing cells to CsA did not
result in any further stress ﬁbre formation (Fig. 5H).
3.6. Eﬀects of E2A transcription factor overexpression on
E-cadherin protein expression in HK-2 tubular epithelial cells
E-cadherin expression in HK-2 tubular epithelial cells was
assessed by Western blot analysis (Fig. 6). Treatment of
mock-transfectants with 4.2 lM CsA resulted in reductions
in E-cadherin levels. Overexpression of E12 resulted in a mod-
est decrease in E-cadherin levels. Treatment of E12-over-
expressing cells with CsA resulted in further downregulation
of E-cadherin. Overexpression of E47 resulted in very signiﬁ-
cant decreases in E-cadherin levels. Treatment of E47-over-
expressing cells with CsA resulted in almost complete loss of
E-cadherin expression. In cells overexpressing E12 and E47
in combination, E-cadherin expression levels were comparable
to levels in E47-overexpressing cells. Treatment of E12 andwere grown on 6-well culture plates. Cells were transfected with equal
ctor or both in combination. Cells were cultured for a further 48 h. (A)
an antibody directed against E2A. (B) b-Actin was used as a loading
t least three independent experiments.
Fig. 4. Eﬀect of E12 and E47 overexpression on tubular epithelial cell morphology. Cellular morphology was assessed using phase contrast
microscopy. HK-2 cells grown on 6-well culture plates were transfected with equal amounts of pcDNA3-E12 expression vector (C,D), pcDNA3-E47
expression vector (E,F) or both in combination (G,H). Cells were treated with control medium (A,C,E,G) or medium containing 4.2 lM CsA
(B,D,F,H) for 48 h (magniﬁcation 100·). Images are representative of at least three independent experiments.
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loss of E-cadherin expression.
3.7. Eﬀects of E2A transcription factor overexpression on
a-SMA expression in HK-2 tubular epithelial cells
a-SMA mRNA levels in HK-2 tubular epithelial cells were
assessed by RT-PCR and a-SMA protein was visualised using
immunoﬂuorescent microscopy (Fig. 7). Treatment of mock-
transfectants with 4.2 lM CsA resulted in increased a-SMA
mRNA levels (Fig. 7A). Overexpression of E12 and E47 indi-
vidually also increased a-SMA mRNA levels but not to the
levels observed with CsA treatment. Overexpression of E12and E47 in combination resulted in similar a-SMA mRNA
levels as those observed in CsA-treated mock-transfectants.
a-SMA protein levels, as assessed by immunoﬂuorescent
microscopy correlated with observed mRNA levels (Fig. 7B)
with overexpression of E12 and E47 in combination resulting
in the highest levels of a-SMA protein expression.4. Discussion
In this current study, we have demonstrated that E2A over-
expression can induce EMT in human RPTEC. EMT is now
Fig. 5. Eﬀect of E12 and E47 overexpression on tubular epithelial cell F-actin cytoskeletal arrangement. HK-2 cells grown on tissue culture slides
were transfected with equal amounts of pcDNA3-E12 expression vector (C,D), pcDNA3-E47 expression vector (E,F) or both in combination (G,H).
Cells were treated with control medium (A,C,E,G) or medium containing 4.2 lM CsA (B,D,F,H) for 48 h. The F-actin cytoskeleton was visualised
using direct immunoﬂuorescence staining with rhodamine phalloidin. Cell nuclei were visualised using direct immunoﬂuorescence staining with
DAPI (magniﬁcation 400·). Images are representative of at least three independent experiments.
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states including renal ﬁbrosis and tumor metastasis [6,20,21].
The development of renal ﬁbrosis and the enhancement of
tumour formation with long term CsA use is now well estab-
lished [22,23]. We have previously demonstrated that CsA-
induced EMT in RPTEC [8,9].
PTECs may no longer be regarded as bystanders in renal dis-
ease development, but as active contributors to renal ﬁbrosis
[24]. After EMT, tubular epithelial cells can migrate to the
interstitium and contribute to disease progression through pro-
duction of ECM, cytokines promoting ﬁbrosis and factorsinducing other epithelial cells to undergo EMT, forming part
of a vicious cycle of ﬁbrosis [4]. EMT can be induced
in vitro by a range of stimuli including ﬁbroblast growth fac-
tor, advanced glycation end products, factors released by acti-
vated immune cells and TGF-b1 [25–28]. The variety of EMT
inducers seems to suggest a multitude of potential mechanisms.
However, Yang and Liu [7] have succinctly described key
events critical to EMT progression, suggesting common down-
stream mechanisms must be involved regardless of the initiat-
ing factors. Since EMT is a gross change in cell phenotype, it
follows that the key events governing the changes occur at the
Fig. 6. Eﬀect of E12 and E47 overexpression on E-cadherin expression in tubular epithelial cells. HK-2 cells were grown on 6-well culture plates.
Cells were transfected with equal amounts of a pcDNA3-E12 expression vector, a pcDNA3-E47 expression vector or both in combination. Cells were
cultured in control medium or medium containing 4.2 lM CsA for 48 h. Whole cell lysates obtained were subjected to SDS–PAGE and probed with
an antibody directed against E-cadherin. b-actin was used as a loading control. Blots shown are representative of at least three independent
experiments. Band intensity was quantiﬁed densitometrically. *(P < 0.05), **(P < 0.01) and ***(P < 0.001) indicates statistically signiﬁcant diﬀerence
compared to control.
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identiﬁed as being upregulated in tubular epithelial cells in re-
sponse to CsA exposure [8]. This was conﬁrmed in the current
study at protein level in nuclear lysates and by immunoﬂuores-
cent microscopy. The E2A gene encodes two basic helix-loop-
helix (bHLH) transcription factors, E12 and E47 [29], which in
combination with other bHLH factors, interact with E-boxes
in the promoters of target genes to modulate their transcrip-
tion [15]. E2A products have been identiﬁed as being involved
in the regulation of a number of genes with relevance to the
EMT process [15]. While mechanisms involved in promoting
E12/E47 transcriptional activity are largely undeﬁned, it has
been proposed that a major factor is the balance between cel-
lular E2A levels and the levels of their inhibitors, Id proteins
(Id1 and Id4 principally) [30]. Thus, the expression levels of
the transcription factors may be a critical determinant of their
activity. In a recent study, Kondo et al. demonstrated that
TGF-b1 treatment resulted in upregulation of E2A transcrip-
tion factors and a concomitant downregulation of Id proteins
[31]. Perez-Moreno et al. demonstrated that transfection ofMDCK renal epithelial cells with a construct encoding the
E47 transcript caused EMT, resulting from repression of E-
cadherin expression in the absence of any other stimulus
[32]. In addition, Kumar et al. have demonstrated the involve-
ment of E2A transcription factors in a-SMA induction in
smooth muscle cells in vivo [33].
In the current model, CsA treatment was seen to result in
marked increases in E12/E47 transcriptional activity tubular
epithelial cells, detected by EMSA, which would result in mod-
ulation of target genes. To further examine the involvement of
E2A transcription factors in this model, E12 and E47 were
overexpressed alone and in combination in tubular epithelial
cells. The eﬀects of E2A protein overexpression were observed
in the absence and presence of CsA to identify what synergistic
eﬀects, if any, might exist. Overexpression of E12 alone had
some eﬀects on cell morphology and F-actin cytoskeletal
arrangement. E12 overexpression also resulted in modest
reductions in E-cadherin expression levels and a concomitant
increase in a-SMA levels. These results suggest that while
E12 is capable of eliciting transcriptional events associated
Fig. 7. Eﬀect of E12 and E47 overexpression on a-SMA expression in tubular epithelial cells. HK-2 cells were grown on 6-well culture plates or tissue
culture slides. Cells were transfected with equal amounts of a pcDNA3-E12 expression vector, a pcDNA3-E47 expression vector or both in
combination. Cells were cultured for a further 48 h. (A) RT-PCR analysis was carried out on RNA obtained using primers speciﬁc to a-SMA. The
GAPDH gene was used as a loading control. Images shown are representative of at least three independent experiments. (B) a-SMA protein was
visualised using indirect immunoﬂuorescence staining. Images are representative of at least three independent experiments.
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ough to eﬀect a gross change in cell morphology. However, the
overexpression of E12 did appear to augment some CsA-in-
duced events, albeit subtly. Overexpression of E47 alone had
major eﬀects on cell morphology and F-actin cytoskeletal
arrangement. The morphology of E47 overexpressing cells
was ﬁbroblast-like with signiﬁcant F-actin rearrangement.
E47 overexpression resulted in signiﬁcant reductions in E-cad-
herin expression levels and a-SMA expression was also in-
duced. The eﬀects of CsA were signiﬁcantly enhanced by the
overexpression of E47. These ﬁndings are in agreement with
observations in other studies that identiﬁed E47 homodimersas being more potent repressors of E-cadherin than E12 homo-
dimers [34,35]. In the present study, the most signiﬁcant eﬀects
on tubular epithelial cell morphology and phenotype were ob-
served with overexpression of E12 and E47 in combination. E-
cadherin expression was severely diminished, a-SMA was
strongly induced and the eﬀects on morphology and F-actin
arrangement were striking with overexpression of both E12
and E47. These eﬀects were augmented slightly by CsA treat-
ment. These results suggest that while overexpression of E2A
transcription factors, individually or in combination, is suﬃ-
cient to induce EMT to varying degrees, other signals induced
by CsA, such as TGF-b1 or PKC-b upregulation [8], also
C. Slattery et al. / FEBS Letters 580 (2006) 4021–4030 4029promote the progression of EMT in the current model, to pro-
vide the maximal response.
This potential role of E2A proteins in CsA-induced EMT is
further supported by investigations into the expression pattern
of E2A in human tissues. Rutherford et al. reported that E2A
proteins were not detectable in adult human kidney samples
[36]. However, E2A expression was detected in the ﬁrst trimes-
ter kidney samples, most abundantly in the primitive, develop-
ing renal tubules, pre-epithelioid cells and renal interstitial
cells, suggesting an association between E2A expression and
mesenchymal cells. This is also in keeping with the proposed
reactivation of developmental pathways in an eﬀort to facili-
tate repair in the damaged kidney [37]. E2A proteins also play
a key role in B and T cell development [38]. E2A protein
expression has also been shown to regulate IgG isotype and
class switching in B-cells [14,39]. Considering this may also
suggest a novel mechanism of CsA’s immunosuppressive
eﬀects.
In conclusion, we provide evidence that upregulation of the
E2A gene may play a key role in CsA-induced EMT in PTECs.
Overexpression of the E2A gene products induced alterations
in cell morphology, cytoskeletal arrangement, and E-cadherin
and a-SMA expression, all hallmarks of the EMT process.
Exploration of the mechanisms involved in this model of
CsA-induced EMT may lead to the development of novel ther-
apeutic targets for the treatment of renal ﬁbrosis, and provide
further insight into the roles and relevance of the E2A tran-
scription factors in disease processes.
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